...
首页> 外文期刊>The Journal of trauma >The effects of decreasing low-molecular weight hemoglobin components of hemoglobin-based oxygen carriers in swine with hemorrhagic shock.
【24h】

The effects of decreasing low-molecular weight hemoglobin components of hemoglobin-based oxygen carriers in swine with hemorrhagic shock.

机译:降低失血性休克猪血红蛋白基氧气载体低分子量血红蛋白成分的作用。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Some hemoglobin-based oxygen carriers (HBOCs) improve outcome in animal models of hemorrhagic shock (HS) in comparison with standard asanguinous resuscitation fluids. Nevertheless, concern about intrinsic vasoactivity, linked in part to low-molecular weight (MW) hemoglobin (Hb), has slowed HBOC development. We assessed the impact of decreasing the low-MW Hb component of bovine HBOC on vasoactivity in severe HS. METHODS: Anesthetized invasively monitored swine were hemorrhaged 55% blood volume and resuscitated with bovine HBOC containing 31% (31 TD [HBOC-301]), 2% (2 TD [HBOC-201]), or 0.4% (0.4 TD) low-MW Hb. Pigs received four 10 mL/kg infusions over 60 minutes, hospital arrival was simulated at 75 minutes, organ blood flow (BF) was evaluated by microsphere injection, and monitoring was continued for 4 hours followed by complete necrotic evaluation. RESULTS: There were few differences between 2 TD and 0.4 TD. Thirty-one TD pigs had higher systemic and pulmonary blood pressure (BP), systemic vascular resistance index, and pulmonary artery wedge pressure, compared with 2 TD or 0.4 TD (p < 0.01); however, pigs in all groups had at least mildly elevated BP. Transcutaneous tissue oxygenation, base excess, and mixed venous oxygen saturation were similar across groups; lactate and methemoglobin were highest with 0.4 TD (p < 0.03). There were no group differences in BF. Over time, myocardial BF increased and hepatic BF decreased in all groups (for 31 TD, p < 0.05); renal BF was unchanged in all groups. There were no group differences in heart, lung, or liver histopathology, and survival. CONCLUSIONS: Although purification from 31% to 2% low-MW Hb content significantly decreased vasoactive responses, further purification to 0.4% had no additional clinically measurable effects in severe HS. If further diminution in HBOC vasoactivity is desired for use in HS, additional technical approaches may be required.
机译:背景:与标准的山楂复苏液相比,某些基于血红蛋白的氧气载体(HBOC)改善了失血性休克(HS)动物模型的预后。尽管如此,对内在血管活性的关注(部分与低分子量(MW)血红蛋白(Hb)相关)已减慢了HBOC的发展。我们评估了降低牛HBOC的低分子量Hb成分对严重HS患者血管活性的影响。方法:麻醉侵入性监测的猪出血55%的血量,并用含有31%(31 TD [HBOC-301]),2%(2 TD [HBOC-201])或0.4%(0.4 TD)低的牛HBOC复苏-MW Hb。猪在60分钟内接受了4次10 mL / kg的输注,在75分钟内模拟了医院的到来,通过微球注射评估了器官的血流(BF),并继续监测了4小时,然后进行了完全坏死的评估。结果:2 TD和0.4 TD之间几乎没有差异。 31只TD猪的全身和肺动脉血压(BP),全身血管阻力指数和肺动脉楔压高于2 TD或0.4 TD(p <0.01);但是,所有组中的猪的血压至少都有轻度升高。各组的经皮组织氧合作用,碱过量和混合静脉血氧饱和度相似。乳酸和高铁血红蛋白最高,为0.4 TD(p <0.03)。高炉无分组差异。随着时间的流逝,所有组的心肌BF增加而肝BF降低(对于31 TD,p <0.05)。所有组的肾BF均未改变。心脏,肺或肝的组织病理学和生存率无分组差异。结论:尽管将低分子量血红蛋白从31%纯化至2%可以显着降低血管活性反应,但进一步纯化至0.4%对重症HS尚无其他临床可测量的作用。如果需要进一步降低HBOC血管活性以用于HS,则可能需要其他技术方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号